To determine if specific Wnt ligands are produced by breast cancer cells in response to IL1β, and to assess if any differences were seen between breast cancer subtypes, Wnt ligand gene expression was assessed in ER+ MCF-7 cells, ER− MDA-MB-231_BH cells, and patient derived samples (n = 3 ER+, n = 3 ER−) following IL1β treatment. Here, IL1B is linked to breast carcinoma.